India  

SII, Bharat Biotech vaccines: Centre calls reports of rejection of emergency approval of Covaxin as 'fake'

DNA Wednesday, 9 December 2020
A team of 70 foreign envoys from several nations visited the Bharat Biotech facility at Genome Valley on Wednesday and were apprised of India's work.
0
shares
ShareTweetSavePostSend
 
Video Credit: Oneindia - Published
News video: Bharat Bandh: Protesting farmers block the Delhi-Meerut highway|Oneindia News

Bharat Bandh: Protesting farmers block the Delhi-Meerut highway|Oneindia News 02:40

Protesting farmers on Tuesday completely blocked Delhi-Meerut expressway at Ghazipur-Ghaziabad border that connects Delhi and Ghaziabad amid their call for Bharat Bandh. The ruling Aam Aadmi Party in Delhi has alleged that CM Arvind Kejriwal has been put under a virtual house arrest since he returned...

You Might Like


💡 newsR Knowledge: Other News Mentions

Bharat Biotech Bharat Biotech Indian biotechnology company and vaccine manufacturer

TN Health Min takes Bharat Biotech's Covaxin shot in Chennai [Video]

TN Health Min takes Bharat Biotech's Covaxin shot in Chennai

The Health and Family Welfare Minister of Tamil Nadu, Dr C Vijayabaskar took Bharat Biotech's Covaxin shot. He took the shot in Chennai on morning of January 22. Dr C Vijayabaskar requested all to get vaccinated and safeguard themselves from COVID-19 pandemic. Billed as the world's largest vaccination programme, covering the entire length and breadth of the country, the drive aims to first inoculate millions of its healthcare and frontline workers and reach an estimated 3 crore people by the end of its first phase. The mega COVID-19 vaccination drive began in India on January 16 (Saturday).

Credit: ANI    Duration: 01:28Published

Expert panel recommends permission for phase 1 clinical trial of Bharat Biotech's nasal vaccine

An expert panel of India's drug regulator CDSCO on Tuesday recommended granting permission for conducting phase 1 clinical trial of an intranasal vaccine against..
IndiaTimes
Healthcare workers should be given choice in vaccines: Karnataka resident doctors [Video]

Healthcare workers should be given choice in vaccines: Karnataka resident doctors

Karnataka Association of Resident Doctors (KARD) has demanded the government to let people choose which COVID-19 vaccine, between Pune-based Serum Institute of India's Covishield and Hyderabad-based Bharat Biotech's Covaxin, they want to take. "Government of India has approved Covishield and Covaxin vaccines. We have all the reports for Covishield. But, Covaxin is still in phase-III trials, where the trial is being done on healthcare workers. We condemn this...Healthcare workers should be given a choice of vaccine," said Dr Dayanand Sagar. GoI rolled out COVID-19 vaccine jab from January 16.

Credit: ANI    Duration: 01:30Published

Serum Institute of India Serum Institute of India Indian biotechnological company, vaccine manufacturer

Watch: India sends SII's Covishield vaccines to Mauritius, Seychelles, Myanmar [Video]

Watch: India sends SII's Covishield vaccines to Mauritius, Seychelles, Myanmar

India dispatched consignments of SII's Covishield to Myanmar, Seychelles and Mauritius. India is sending Covid-19 vaccines as part of donation program to neighbours and key partners. Bhutan, Maldives, Bangladesh, Nepal were also part of India's initial rollout of vaccines. In addition, India plans to supply vaccine doses to Afghanistan and Sri Lanka. Covishield's commercial supplies to countries having agreements with SII have also begun. Two flights are slated to carry two million doses each to Brazil and Morocco on Friday. India is carrying out vaccine diplomacy under its 'Neighbourhood First' policy. Last week, India launched the world's biggest Covid-19 vaccination drive across the country.

Credit: HT Digital Content    Duration: 02:46Published

India to send SII's COVID-19 vaccine 'Covishield' to Myanmar, Seychelles, Mauritius

The Ministry of External Affairs had announced a vaccine rollout for Bhutan, Maldives, Bangladesh, Nepal, Myanmar and Seychelles from Wednesday.
DNA
COVID vaccine ready for dispatch to Myanmar, Seychelles, Mauritius from Mumbai airport [Video]

COVID vaccine ready for dispatch to Myanmar, Seychelles, Mauritius from Mumbai airport

Serum Institute of India's vaccine consignment arrived at Mumbai's Chhatrapati Shivaji Maharaj International Airport on January 22. The consignment containing COVID-19 vaccine will be dispatched to Myanmar, Seychelles and Mauritius.

Credit: ANI    Duration: 01:17Published

Related videos from verified sources

India launches world's largest vaccination drive [Video]

India launches world's largest vaccination drive

India on Saturday (January 16) launched the world's largest vaccination drive after receiving millions of doses of two approved vaccines - Covishield and Covaxin.

Credit: Newsflare STUDIO     Duration: 02:05Published
Covid vaccine: How many Indians got jab on Day 1? Govt reveals [Video]

Covid vaccine: How many Indians got jab on Day 1? Govt reveals

At least 1,65,714 healthcare beneficiaries received COVID-19 jab on Saturday across India, marking it as a historic and biggest COVID-19 vaccination drive launched by Prime Minister Narendra Modi...

Credit: HT Digital Content     Duration: 06:46Published
First feeling, side-effects, doubts: Vaccinated doctors share experience [Video]

First feeling, side-effects, doubts: Vaccinated doctors share experience

On Day 1 of India's Covid-19 vaccination, two doctors who took the shots shared their experience. Dr Atul Peters and Anil Dhar of Max hospital were given Bharat Biotech's Covaxin and SII-made..

Credit: HT Digital Content     Duration: 08:15Published

Related news from verified sources

Covid-19: 40-50m shots stockpiled by SII, India to get most of it

India will initially get most of the 40-50 million ‘Covishield’ vaccine shots stockpiled by the Serum Institute of India (SII), since exports would require...
IndiaTimes

COVID-19: India may get vaccine nod for emergency use by year-end

India is likely to have a COVID-19 vaccine approved for emergency use before December ends as Central Drugs Standard Control Organization's (CDSCO) expert panel...
Mid-Day Also reported by •Zee NewsIndiaTimes

Covishield safe, immunogenic; incident with Chennai volunteer no way induced by vaccine: SII

Stressing that the Covishield vaccine is "safe and immunogenic", the Serum Institute of India (SII) on Tuesday said the incident with the Chennai volunteer was...
Mid-Day Also reported by •Zee News